Immunogenicity and acceptance of influenza A (H1N1) vaccine in a cohort of chronic hepatitis C patients receiving pegylated-interferon treatment

scientific article

Immunogenicity and acceptance of influenza A (H1N1) vaccine in a cohort of chronic hepatitis C patients receiving pegylated-interferon treatment is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2012PLoSO...748610H
P356DOI10.1371/JOURNAL.PONE.0048610
P8608Fatcat IDrelease_mxqru76olned7pc77rmy6slpsu
P932PMC publication ID3493585
P698PubMed publication ID23144908
P5875ResearchGate publication ID233397036

P50authorTomàs Pumarola SuñéQ41886172
Enrique QuinteroQ54231193
P2093author name stringAlvaro Torres
Patricia de Molina
Antonio Z Gimeno-García
Manuel Hernández-Guerra
Alejandro Jimenez
Carlos Casanova
Miriam Hernández-Porto
Marta Carrillo
Yanira González-Méndez
P2860cites workThe influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccineQ69741135
Immune response to influenza vaccine in adult liver transplant recipientsQ73753116
Immune response to influenza vaccine in pediatric patients with inflammatory bowel diseaseQ80420684
Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cellsQ27469883
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialQ27860949
Type I IFN as a vaccine adjuvant for both systemic and mucosal vaccination against influenza virusQ28250640
Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspectiveQ28740919
Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.Q30227381
Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys.Q30380132
Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009.Q30380173
Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.Q30380578
A novel influenza A (H1N1) vaccine in various age groups.Q30381838
Seasonal and Pandemic A (H1N1) 2009 influenza vaccination coverage and attitudes among health-care workers in a Spanish University Hospital.Q30389171
Acceptance of seasonal and pandemic a (H1N1) 2009 influenza vaccination by healthcare workers in a french teaching hospitalQ30401918
Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, SwedenQ30408080
Immunogenicity and protective efficacy of influenza vaccinationQ35784255
Development and psychometric validation of a self-administered questionnaire assessing the acceptance of influenza vaccination: the Vaccinees' Perception of Injection (VAPI) questionnaireQ37139129
Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infectionQ37359927
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin.Q38876960
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation?Q39371548
Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel diseaseQ42609131
Impaired serum antibody response to inactivated influenza A and B vaccine in cancer patientsQ42927446
Immunogenicity and safety of an adjuvanted influenza vaccine in patients with decompensated cirrhosis.Q43906914
Rate of infectious complications during interferon-based therapy for hepatitis C is not related to neutropeniaQ43970118
Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive modelQ44151781
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.Q44527614
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionQ44920531
Risk factors for infection during treatment with peginterferon alfa and ribavirin for chronic hepatitis C.Q50558699
Treatment with PEG-interferon and ribavirin for chronic hepatitis C increases neutrophil and monocyte chemotaxis.Q50561780
Bacterial infection and neutropenia during peginterferon plus ribavirin combination therapy in patients with chronic hepatitis C with and without baseline neutropenia in clinical practice.Q50564459
Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C.Q50583960
Adjuvant activity of interferon alpha: mechanism(s) of action.Q50724369
H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy.Q51512458
Severe influenza infection in a chronic hepatitis C carrier: failure of protective serum HI antibodies after IM vaccination.Q51638761
Influenza vaccination in patients with cirrhosis and in liver transplant recipients.Q51834442
Type I interferon (IFN alpha) acts directly on human memory CD4+ T cells altering their response to antigen.Q51891189
Humoral and cellular immune responses to influenza vaccine in patients with advanced cirrhosis.Q53606111
FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10–11, 2007Q54691178
Strategic Advisory Group of Experts on Immunization - report of the extraordinary meeting on the influenza A (H1N1) 2009 pandemic, 7 July 2009Q57110819
Immunogenicity and safety of influenza vaccination in children with inflammatory bowel diseaseQ59563630
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectchronic hepatitis CQ55779873
P304page(s)e48610
P577publication date2012-11-08
P1433published inPLOS OneQ564954
P1476titleImmunogenicity and acceptance of influenza A (H1N1) vaccine in a cohort of chronic hepatitis C patients receiving pegylated-interferon treatment
P478volume7

Reverse relations

Q93172586Effectiveness of influenza vaccines in adults with chronic liver disease: a systematic review and meta-analysiscites workP2860